Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GENB | AZN | AMGN | GILD | BMY |
| Company | Generate Biomedicines Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.72 | 185.45 | 332.52 | 130.00 | 60.02 |
| High | 12.98 | 187.18 | 337.00 | 131.51 | 60.09 |
| Low | 12.50 | 184.26 | 325.44 | 129.01 | 58.03 |
| Latest | 12.94 | 184.98 | 325.25 | 130.86 | 58.89 |
| Change | +0.31 | -2.39 | -21.00 | +0.02 | -1.70 |
| % Change | +2.45% | -1.28% | -6.06% | +0.02% | -2.81% |
| Volume | 32,380 | 713,052 | 1,420,213 | 1,118,689 | 6,096,067 |
| 20-Day Average Volume | 320,296 | 1,981,559 | 2,433,695 | 5,118,312 | 9,226,004 |
| Previous Close | 12.63 | 187.37 | 346.25 | 130.84 | 60.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.42 | 196.74 | 345.87 | 135.52 | 58.78 |
| 20-Day Raw Stochastic | 63.76% | 11.73% | 2.11% | 19.34% | 45.22% |
| 20-Day Relative Strength | 52.51 | 39.53 | 36.99 | 39.40 | 49.83 |
| Weighted Alpha | N/A | +23.60 | +12.09 | +20.96 | +21.45 |
| Today's Opinion | N/A | 24% Buy | 8% Sell | 8% Sell | 56% Buy |
| Previous Opinion | N/A | 40% Buy | 8% Buy | Hold | 72% Buy |
| Last Month's Opinion | N/A | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.02% since 04/24/26 | -2.65% since 04/24/26 | -5.19% since 04/24/26 | +0.16% since 04/24/26 | +0.20% since 04/24/26 |
| Low | 12.03 on 04/29/26 | 181.73 on 04/29/26 | 325.98 on 05/01/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 13.45 on 04/27/26 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.21 on 04/30/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -2.85% since 04/01/26 | -7.97% since 04/01/26 | -7.53% since 04/01/26 | -6.91% since 04/01/26 | -4.70% since 04/01/26 |
| Low | 11.10 on 04/10/26 | 181.73 on 04/29/26 | 325.98 on 05/01/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 14.21 on 04/02/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | N/A since 02/27/26 | -0.44% since 01/30/26 | -4.44% since 01/30/26 | -7.99% since 01/30/26 | +6.87% since 01/30/26 |
| Low | 11.00 on 03/04/26 | 181.73 on 04/29/26 | 325.98 on 05/01/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 15.32 on 02/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | N/A since 02/27/26 | +12.09% since 10/31/25 | +9.47% since 10/31/25 | +9.03% since 10/31/25 | +27.70% since 10/31/25 |
| Low | 11.00 on 03/04/26 | 160.96 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 15.32 on 02/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,609,694 | 290,593,632 | 186,865,936 | 162,401,488 | 123,708,720 |
| Shares Outstanding, K | 127,450 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 31,893,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -203,154,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | N/A | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | N/A | 08/04/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.00 | 15.47 | 15.81 | 9.36 |